vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ICF International, Inc. (ICFI). Click either name above to swap in a different company.
ICF International, Inc. is the larger business by last-quarter revenue ($437.5M vs $268.1M, roughly 1.6× ACADIA PHARMACEUTICALS INC). ICF International, Inc. runs the higher net margin — 4.7% vs 1.4%, a 3.3% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -10.3%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -7.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
ICF International, Inc. is an American publicly traded consulting and technology services company based in Reston, Virginia.
ACAD vs ICFI — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $437.5M |
| Net Profit | $3.6M | $20.5M |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 8.0% |
| Net Margin | 1.4% | 4.7% |
| Revenue YoY | 9.7% | -10.3% |
| Net Profit YoY | — | -23.6% |
| EPS (diluted) | $0.02 | $1.12 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | $437.5M | ||
| Q4 25 | $284.0M | $443.7M | ||
| Q3 25 | $278.6M | $465.4M | ||
| Q2 25 | $264.6M | $476.2M | ||
| Q1 25 | $244.3M | $487.6M | ||
| Q4 24 | $259.6M | $496.3M | ||
| Q3 24 | $250.4M | $517.0M | ||
| Q2 24 | $242.0M | $512.0M |
| Q1 26 | $3.6M | $20.5M | ||
| Q4 25 | $273.6M | $17.3M | ||
| Q3 25 | $71.8M | $23.8M | ||
| Q2 25 | $26.7M | $23.7M | ||
| Q1 25 | $19.0M | $26.9M | ||
| Q4 24 | $143.7M | $24.6M | ||
| Q3 24 | $32.8M | $32.7M | ||
| Q2 24 | $33.4M | $25.6M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | 35.7% | ||
| Q3 25 | 92.2% | 37.6% | ||
| Q2 25 | 92.2% | 37.3% | ||
| Q1 25 | 91.7% | 38.0% | ||
| Q4 24 | 91.6% | 36.1% | ||
| Q3 24 | 92.5% | 37.1% | ||
| Q2 24 | 92.5% | 35.7% |
| Q1 26 | -1.7% | 8.0% | ||
| Q4 25 | 6.1% | 6.5% | ||
| Q3 25 | 12.8% | 8.3% | ||
| Q2 25 | 12.2% | 8.4% | ||
| Q1 25 | 7.9% | 7.9% | ||
| Q4 24 | 59.1% | 7.3% | ||
| Q3 24 | 12.6% | 8.9% | ||
| Q2 24 | 12.6% | 8.3% |
| Q1 26 | 1.4% | 4.7% | ||
| Q4 25 | 96.3% | 3.9% | ||
| Q3 25 | 25.8% | 5.1% | ||
| Q2 25 | 10.1% | 5.0% | ||
| Q1 25 | 7.8% | 5.5% | ||
| Q4 24 | 55.4% | 4.9% | ||
| Q3 24 | 13.1% | 6.3% | ||
| Q2 24 | 13.8% | 5.0% |
| Q1 26 | $0.02 | $1.12 | ||
| Q4 25 | $1.61 | $0.95 | ||
| Q3 25 | $0.42 | $1.28 | ||
| Q2 25 | $0.16 | $1.28 | ||
| Q1 25 | $0.11 | $1.44 | ||
| Q4 24 | $0.86 | $1.29 | ||
| Q3 24 | $0.20 | $1.73 | ||
| Q2 24 | $0.20 | $1.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $3.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $1.6B | $2.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $3.9M | ||
| Q4 25 | $177.7M | $5.3M | ||
| Q3 25 | $258.0M | $4.0M | ||
| Q2 25 | $253.6M | $7.0M | ||
| Q1 25 | $217.7M | $5.7M | ||
| Q4 24 | $319.6M | $5.0M | ||
| Q3 24 | $155.1M | $6.9M | ||
| Q2 24 | $177.1M | $4.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $401.4M | ||
| Q3 25 | — | $449.4M | ||
| Q2 25 | — | $462.3M | ||
| Q1 25 | — | $502.0M | ||
| Q4 24 | — | $411.7M | ||
| Q3 24 | — | $419.1M | ||
| Q2 24 | — | $433.9M |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $1.0B | ||
| Q3 25 | $917.3M | $1.0B | ||
| Q2 25 | $822.4M | $1.0B | ||
| Q1 25 | $765.2M | $968.9M | ||
| Q4 24 | $732.8M | $982.5M | ||
| Q3 24 | $577.2M | $976.3M | ||
| Q2 24 | $516.7M | $943.3M |
| Q1 26 | $1.6B | $2.1B | ||
| Q4 25 | $1.6B | $2.1B | ||
| Q3 25 | $1.3B | $2.1B | ||
| Q2 25 | $1.2B | $2.1B | ||
| Q1 25 | $1.1B | $2.1B | ||
| Q4 24 | $1.2B | $2.1B | ||
| Q3 24 | $976.9M | $2.0B | ||
| Q2 24 | $914.1M | $2.0B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.39× | ||
| Q3 25 | — | 0.44× | ||
| Q2 25 | — | 0.46× | ||
| Q1 25 | — | 0.52× | ||
| Q4 24 | — | 0.42× | ||
| Q3 24 | — | 0.43× | ||
| Q2 24 | — | 0.46× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
